Feline SDMA Test: An Important Tool for Early Kidney Health Assessment in Cats

Chronic kidney disease is very common in middle‑aged and senior cats, and it often progresses without obvious early signs. By the time owners notice increased drinking, weight loss, or reduced appetite, a considerable amount of renal function may already be lost.

SDMA (symmetric dimethylarginine) is a small molecule generated during protein metabolism and eliminated primarily through glomerular filtration. Unlike creatinine, which typically remains within normal limits until roughly 75% of renal function is lost, SDMA concentrations begin to rise as soon as filtration efficiency starts to decline. This makes it a more sensitive marker for early renal changes.

Two brief cases illustrate the point. An 11‑year‑old spayed female domestic shorthair presented for a routine annual check with no owner concerns. Routine biochemistry showed creatinine and BUN within reference ranges, but SDMA was mildly elevated at 16 µg/dL (upper reference limit 14 µg/dL). Further investigation revealed slight proteinuria and a systolic blood pressure of 155 mmHg. A renal‑supportive diet was initiated. At three‑month follow‑up, SDMA had decreased to 14 µg/dL, proteinuria improved, blood pressure stabilised, and the cat maintained body weight and normal activity.

In a second case, a 14‑year‑old neutered male Persian with stable hyperthyroidism on methimazole presented with polyuria and a 200 g weight loss over four months. Blood work showed creatinine 2.2 mg/dL, BUN 36 mg/dL, and SDMA 22 µg/dL, with a urine specific gravity of 1.020 and systolic blood pressure of 160 mmHg. The cat was started on a renal diet and low‑dose amlodipine, while methimazole dosing was closely monitored. At three months, SDMA had dropped to 17 µg/dL, creatinine to 1.9 mg/dL, urine specific gravity improved to 1.028, and blood pressure normalised. Weight stabilised and drinking returned to baseline.

In both cases, SDMA provided an earlier indication of renal dysfunction than traditional markers alone, allowing dietary or pharmacological adjustments before more advanced changes occurred.

That said, SDMA should not be interpreted in isolation. It is most useful when combined with urinalysis, blood pressure measurement, and clinical history. Transient elevations can occur with dehydration, which does not necessarily indicate intrinsic renal disease. For senior cats, those with polydipsia or polyuria, and patients on long‑term medication, periodic SDMA measurement offers a practical means of monitoring renal status. Earlier recognition does not guarantee a cure, but it may buy additional time for intervention and help preserve quality of life.